For Now, Competitive Generic Therapy Exclusivity Is A Mirage
Exorbitantly high prices are not just a problem for patented drugs. Even off-patent drugs are subject to high prices when there is inadequate generic competition due to market size or regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article